Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort

被引:70
|
作者
Vermeer, Marloes [1 ,2 ]
Kuper, Hillechiena H. [2 ]
Moens, Hein J. Bernelot [3 ]
Hoekstra, Monique [4 ]
Posthumus, Marcel D. [5 ]
van Riel, Piet L. C. M. [6 ]
van de Laar, Mart A. F. J. [1 ,2 ]
机构
[1] Univ Twente, Dept Psychol Hlth & Technol, Arthrit Ctr Twente, NL-7500 AE Enschede, Netherlands
[2] Dept Rheumatol & Clin Immunol, NL-7500 KA Enschede, Netherlands
[3] Ziekenhuisgrp Twente, Dept Rheumatol, NL-7550 AM Hengelo, Netherlands
[4] Isala Klin, Dept Rheumatol, NL-8000 GM Zwolle, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 RB Groningen, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands
关键词
DAILY CLINICAL-PRACTICE; DISEASE-ACTIVITY; AMERICAN-COLLEGE; TIGHT CONTROL; 28-JOINT COUNTS; ESCALATE CARE; RHEUMATOLOGISTS; RECOMMENDATIONS; TRIALS; DAS28;
D O I
10.1186/ar4099
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The objective of the study was to evaluate the adherence to a T2T strategy aiming at remission (Disease Activity Score in 28 joints (DAS28) < 2.6) in early RA in daily practice. The recommendations regarding T2T included regular assessment of the DAS28 and advice regarding DAS28-driven treatment adjustments. Methods: A medical chart review was performed among a random sample of 100 RA patients of the DREAM remission induction cohort. At all scheduled visits, it was determined whether the clinical decisions were compliant to the T2T recommendations. Results: The 100 patients contributed to a total of 1,115 visits. The DAS28 was available in 97.9% (1,092/1,115) of the visits, of which the DAS28 was assessed at a frequency of at least every three months in 88.3% (964/1,092). Adherence to the treatment advice was observed in 69.3% (757/1,092) of the visits. In case of non-adherence when remission was present (19.5%, 108/553), most frequently medication was tapered off or discontinued when it should have been continued (7.2%, 40/553) or treatment was continued when it should have been tapered off or discontinued (6.2%, 34/553). In case of non-adherence when remission was absent (42.1%, 227/539), most frequently medication was not intensified when an intensification step should have been taken (34.9%, 188/539). The main reason for non-adherence was discordance between disease activity status according to the rheumatologist and DAS28. Conclusions: The recommendations regarding T2T were successfully implemented and high adherence was observed. This demonstrates that a T2T strategy is feasible in RA in daily clinical practice.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Achievement of Remission in Two Early Rheumatoid Arthritis Inception Cohorts Implementing Different Treat-to-Target Strategies
    Norvang, Vibeke
    Brinkmann, Gina Hetland
    Sexton, Joseph
    Aga, Anna-Birgitte
    Lillegraven, Siri
    Uhlig, Till
    Kvien, Tore
    Mjaavatten, Maria Dahl
    Haavardsholm, Espen A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] TREAT-TO-TARGET IS FEASIBLE IN RHEUMATOID ARTHRITIS PATIENTS DURING PREGNANCY, FIRST RESULTS OF THE PRECARA COHORT
    Smeele, H. T.
    Roder, E.
    Wintjes, H.
    Kranenburg-van Koppen, L. J.
    Hazes, J.
    Dolhain, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1885 - 1886
  • [33] DOES POLYPHARMACY IN RHEUMATOID ARTHRITIS PATIENTS AFFECT THE TREAT-TO-TARGET STRATEGY?
    Jaramillo Gallego, John Fredy
    Rosa, Javier
    Scolnik, Marina
    Tobar Jaramillo, Maya Alejandra
    Garcia, Maria Victoria
    Ferreyra, Leandro
    Soriano, E. R.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 13 - 14
  • [34] Rheumatoid Arthritis: How well does the Treat-to-Target Strategy work?
    Lorenz, Judith
    [J]. AKTUELLE RHEUMATOLOGIE, 2020, 45 (04) : 266 - 266
  • [35] WORK DISABILITY IN AN INCEPTION COHORT OF EARLY RHEUMATOID ARTHRITIS (RA) RECEIVING TREAT-TO-TARGET THERAPY
    Lester, S.
    Hill, C.
    Shanahan, E.
    Metcalf, R.
    Shanahan, M.
    Proudman, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 30 - 30
  • [36] MRI OF THE WRIST IN EARLY RHEUMATOID ARTHRITIS AFTER 1-YEAR TREAT-TO-TARGET STRATEGY
    Xiao Fan
    Griffith, James F.
    Tam, Lai-Shan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 257 - 257
  • [37] MRI of the Wrist in Early Rheumatoid Arthritis After 1-year Treat-to-target Strategy
    Xiao, Fan
    Ko, Jacky Ka
    Yue, Jiang
    Griffith, James
    Tam, Lai-Shan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
    Song, Jason Jungsik
    Song, Yeong Wook
    Bae, Sang Cheol
    Cha, Hoon-Suk
    Choe, Jung-Yoon
    Choi, Sung Jae
    Kim, Hyun Ah
    Kim, Jinseok
    Kim, Sung-Soo
    Lee, Choong-Ki
    Lee, Jisoo
    Lee, Sang-Heon
    Lee, Shin-Seok
    Lee, Soo-Kon
    Lee, Sung Won
    Park, Sung-Hwan
    Park, Won
    Shim, Seung Cheol
    Suh, Chang-Hee
    Yoo, Bin
    Yoo, Dae-Hyun
    Yoo, Wan-Hee
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (52)
  • [39] ADDING ULTRASOUND TO THE TREAT-TO-TARGET STRATEGY SHOWS NO BENEFIT IN ACHIEVEMENT OF REMISSION: RESULTS FROM THE BIODAM COHORT
    Sepriano, A.
    Ramiro, S.
    Landewe, R.
    van der Heijde, D.
    Ohrndorf, S.
    FitzGerald, O.
    Backhaus, M.
    Larche, M.
    Homik, J.
    Saraux, A.
    Hammer, H.
    Terslev, L.
    Ostergaard, M.
    Burmester, G.
    Combe, B.
    Dougados, M.
    Hitchon, C.
    Boire, G.
    Dadashova, R.
    Paschke, J.
    Hutchings, E.
    Maksymowych, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 131 - 131
  • [40] Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study
    Schapink, Lisa
    den Broeder, Nathan
    den Broeder, Alfons A.
    Verhoef, Lise M.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2024,